drugset / Trial / NCT00884052
Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
NaSingle-groupOpen-labelTreatment
Summary
The hypothesis is that a loading dose of 20 mg/kg and a maintenance dose of 5 mg/kg of Levetiracetam is going to be safe and effective in the treatment of seizures in neonates.
Timeline
- Start
- 2007-04
- Primary completion
- 2011-03
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 5 mg/kg | Intravenous |
| Subject | Levetiracetam | Other / unclassified | 10 mg/kg | Intravenous |